These results demonstrate that the triple therapy produces CTL responses that are greater than debulk alone, or debulk with either IMQ or anti-CD40 therapy.We also analysed T cell subset distribution and activation status in the dLN, spleen and tumour following each of the different treatment combinations. This evidence concerns the gene CD40 and neoplasm.